Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SRRM2 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP19060925UL
Description
SRRM2 Polyclonal specifically detects SRRM2 in Human samples. It is validated for Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
SRRM2 | |
Polyclonal | |
Immunohistochemistry 1:500 - 1:1000, Immunocytochemistry/Immunofluorescence 1 - 4 ug/ml, Immunohistochemistry-Paraffin 1:500 - 1:1000 | |
Q9UQ35 | |
SRRM2 | |
This antibody was developed against Recombinant Protein corresponding to amino acids:RSRSSSPVTELASRSPIRQDRGEFSASPMLKSGMSPEQSRFQSDSSSYPTVDSNSLLGQSRLETAESKEKMALPPQEDATASPPRQKDKFSPFPVQDRPESSLVFK | |
25 μL | |
Primary | |
Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
Unconjugated | |
PBS (pH 7.2) and 40% Glycerol with 0.02% Sodium Azide | |
Cwc21, CWF21, DKFZp667L0421,300 kDa nuclear matrix antigen, DKFZp686O15166,300-KD, FLJ21926, FLJ22250, HSPC075, KIAA0324, MGC40295, RNA binding protein, ser/Arg-related nuclear matrix protein of 300 kDa, serine/arginine repetitive matrix 2, serine/arginine repetitive matrix protein 2, serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa, splicing coactivator subunit SRm300, SRL300, SRm300, SR-related nuclear matrix protein of 300 kDa, taxREB803, tax-responsive enhancer element-binding protein 803 | |
Rabbit | |
Affinity Purified | |
RUO | |
23524 | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction